Wolfgang Miesbach: Cognitive Impairment in aPL-Positive Patients
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Cognitive impairment in aPL-positive patients.
An important presentation by Gustavo Balbi and colleagues on the real-world recognition and management of cognitive impairment in patients with antiphospholipid antibodies (aPL).
Clinicians most frequently associated aPL with depression, anxiety, impaired attention, slower processing speed, and memory or executive dysfunction.
Yet routine cognitive screening remains uncommon – particularly in patients without stroke and TIA or overt symptoms.
Stronger collaboration between APS specialists, cognitive neurologists, and neuropsychologists is urgently needed to improve recognition, assessment, and care.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH